SPNS2
protein-codingSPNS lysolipid transporter 2, sphingosine-1-phosphate, the group of Solute carrier family 63, sphingosine phosphate transporters
Gene summary
The protein encoded by this gene is a transporter of sphingosine 1-phosphate, a secreted lipid that is important in cardiovascular, immunological, and neural development. Defects in this gene are a cause of early onset progressive hearing loss. [provided by RefSeq, Jul 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032762
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032762
Submitter: ClinGen
SPNS2 was first reported in relation to autosomal recessive nonsyndromic hearing loss in 2019 (Ingham et al., PMID: 30973865). Onset of this hearing loss is in infancy/early childhood and has been observed as downsloping and high-frequency. Four variants (missense, inframe deletion, frameshift, nonsense) that have been reported in two probands in two publications are included in this curation (PMIDs: 30973865, 36494063). The mechanism of pathogenicity appears to be loss of function (30973865). This gene-disease relationship is also supported by experimental evidence (mouse models, rescue evidence, expression level data; PMIDs: 25356849, 37552762). Homozygous knockout mice have progressive hearing loss, reduced endocochlear potential, and ocular anomalies (such as corneal opacity). The hearing phenotype was rescued in mice that received a recombinase allele and tamoxifen injection. Expression-level data shows strong expression of the gene in the cochlea (specifically the lateral wall and Organ of Corti) in wild-type mice, but significantly reduced expression in mutants. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date 7/15/2026 (SOP Version 12).
Inheritance Pattern: Unknown
Disease ID:MONDO:0032762
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SPNS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001124758.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 21 | 2 | 25 | ||
| missense | 108 | 7 | 2 | 117 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 3 | 113 | 28 | 4 | 148 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001118230.1 | 12 | MANE Select | |
| Ensembl | ENSP00000333292.3 | 12 | MANE Select | |
| Ensembl | ENSP00000461410.1 | 6 | Standard | |
| Ensembl | ENSP00000602092.1 | 11 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| spns2 | Danio rerio | Structure: median fin Quality: blistered abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- B cell homeostasis
- regulation of humoral immune response
- sphingosine-1-phosphate receptor signaling pathway
- sphingolipid metabolic process
- lipid transport
Molecular Function
- sphingolipid transporter activity
Cellular Component
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000329078
- Coding exons
- 12
- Length
- 40198
- Individuals with no LoFs
- 124692
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 33
- Defined
- 124725
- p
- 0.000132
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0679 | 315 | 312 | 1.01 | 0.0000203 | 3457 |
| Missense (PolyPhen) | 105 | 122.03 | 0.86043 | 1252 | ||
| Synonymous | -4.15 | 203 | 140 | 1.45 | 0.0000100 | 1205 |
| Loss of Function | 2.31 | 12 | 24.3 | 0.494 | 0.00000128 | 260 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00017 | 0.00017 | rare |
| Finnish | 0.000093 | 0.000093 | rare |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Sphingolipid transporter required for migration of myocardial precursors. Transports sphingosine 1-phosphate (S1P), a secreted lipid mediator that plays critical roles in cardiovascular, immunological, and neural development and function. Mediates the export of S1P from cells in the extraembryonic yolk syncytial layer (YSL), thereby regulating myocardial precursor migration. {ECO:0000269|PubMed:19074308}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- LoFtool
- 0.572
- RVIS EVS
- -0.98
- RVIS percentile EVS
- 8.85
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.270
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |